Business of Optometry

Top Story

Intranasal stimulator increased tear production in trials

May 26, 2016

Allergan announced that a premarket submission for Oculeve Intranasal Tear Neurostimulator will be submitted to the FDA in the second half of 2016, following two pivotal trials that met their primary and secondary efficacy endpoints.

The handheld stimulator and daily disposable tips increase tear production upon stimulation in patients with dry eye disease due to decreased tear production, according to a press release from the company.

Valeant names senior vice president and corporate controller

May 26, 2016
Valeant Pharmaceuticals International announced it has named Sam Eldessouky senior vice president and corporate controller.Eldessouky, with more than 20 years of…

Robert E. Grant transitions from CEO to board vice chairman of Alphaeon

May 26, 2016
Robert E. Grant, founder of Alphaeon, will transition from his role as CEO to the role of vice chairman of the company’s board of directors, according to an…

Ophthotech reports $36.3 million net loss in first quarter

May 20, 2016
Ophthotech reported a first quarter net loss of $36.3 million, or $1.03 per diluted share, compared with a net income of $6.6 million, or $0.19 per diluted share, in the…

Intranasal stimulator increased tear production in trials

May 26, 2016
Allergan announced that a premarket submission for Oculeve Intranasal Tear Neurostimulator will be submitted to the FDA…
More »

AOA pediatric clinical practice guideline available for public review

May 25, 2016
The American Optometric Association announced its new clinical practice guideline on pediatric eye health is available…
More »
Featured
ARVO

ARVO

In the Journals

Routine eye exams detect new eye conditions in asymptomatic patients

May 27, 2016
Researchers found that more than half of the asymptomatic patients who presented for a routine eye exam had a change in…
More »

Intranasal stimulator increased tear production in trials

May 26, 2016
Allergan announced that a premarket submission for Oculeve Intranasal Tear Neurostimulator will be submitted to the FDA in the second half of 2016…

Valeant names senior vice president and corporate controller

May 26, 2016
Valeant Pharmaceuticals International announced it has named Sam Eldessouky senior vice president and corporate controller.Eldessouky, with more…

Robert E. Grant transitions from CEO to board vice chairman of Alphaeon

May 26, 2016
Robert E. Grant, founder of Alphaeon, will transition from his role as CEO to the role of vice chairman of the company’s board of directors…

Ophthotech reports $36.3 million net loss in first quarter

May 20, 2016
Ophthotech reported a first quarter net loss of $36.3 million, or $1.03 per diluted share, compared with a net income of $6.6 million, or $0.19 per…

New smart glasses designed to aid patients with low vision

May 19, 2016
NuEyes and Osterhout Design Group announced the release of portable smart glasses for patients with low vision.Osterhout Design Group (ODG) combined…

TearScience releases dynamic meibomian gland imager

May 18, 2016
TearScience introduced the LipiScan, which dynamically images the meibomian glands in high definition.The LipiScan was designed to produce…

Refocus completes patient enrollment for potential presbyopia treatment

May 17, 2016
Enrollment is complete for a phase 3 clinical trial of the VisAbility Micro-Insert System for treatment of presbyopia, according to press release…

Meeting News CoverageFrom OSN Europe

Mauritania approaching goal of trachoma eradication thanks to private funding

May 17, 2016
PARIS — The ambitious goal of lowering the prevalence of blinding trachoma from 16% to less than 3% in Mauritania was achieved thanks to…

Bausch + Lomb, CooperVision reaffirm their stances on UPPs

May 11, 2016
In light of Johnson & Johnson Vision Care’s April announcement that the company would be discontinuing its unilateral pricing policy…

Allergan announces stock repurchase plan

May 10, 2016
Allergan plc announced in a press release that its board of directors has authorized a share repurchase program of up to $10 billion of the…

More Headlines »
morganatic-roan
morganatic-roan